Artículos con órdenes de acceso público - Javier sanchoMás información
No disponible en ningún lugar: 1
Mechanism of FMN Binding to the Apoflavodoxin from Helicobacter pylori
S Ayuso-Tejedor, O Abian, A Velazquez-Campoy, J Sancho
Biochemistry 50 (40), 8703-8711, 2011
Órdenes: Gobierno de España
Disponibles en algún lugar: 64
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
J Pujols, S Peña-Díaz, DF Lázaro, F Peccati, F Pinheiro, D González, ...
Proceedings of the National Academy of Sciences 115 (41), 10481-10486, 2018
Órdenes: German Research Foundation, European Commission, Gobierno de España
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
AL Pey, M Ying, N Cremades, A Velazquez-Campoy, T Scherer, B Thöny, ...
The Journal of clinical investigation 118 (8), 2858-2867, 2008
Órdenes: Swiss National Science Foundation, US National Institutes of Health
ProtSA: a web application for calculating sequence specific protein solvent accessibilities in the unfolded ensemble
J Estrada, P Bernadó, M Blackledge, J Sancho
BMC bioinformatics 10 (1), 1, 2009
Órdenes: US National Institutes of Health
Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains
V Espinosa Angarica, S Ventura, J Sancho
BMC genomics 14, 1-17, 2013
Órdenes: Gobierno de España
High-throughput screening methodology to identify alpha-synuclein aggregation inhibitors
J Pujols, S Peña-Díaz, M Conde-Giménez, F Pinheiro, S Navarro, ...
International journal of molecular sciences 18 (3), 478, 2017
Órdenes: Gobierno de España
Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents against Helicobacter pylori Infection
N Cremades, A Velázquez-Campoy, M Martínez-Júlvez, JL Neira, ...
ACS Chemical Biology 4 (11), 928-938, 2009
Órdenes: US National Institutes of Health
Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and …
O Abian, P Alfonso, A Velazquez-Campoy, P Giraldo, M Pocovi, J Sancho
Molecular pharmaceutics 8 (6), 2390-2397, 2011
Órdenes: Gobierno de España
Structure of RdxA – an oxygen‐insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori
M Martínez‐Júlvez, AL Rojas, I Olekhnovich, VE Angarica, PS Hoffman, ...
The FEBS journal 279 (23), 4306-4317, 2012
Órdenes: US National Institutes of Health, Gobierno de España
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
A González, S Salillas, A Velázquez-Campoy, V Espinosa Angarica, ...
Scientific reports 9 (1), 11294, 2019
Órdenes: Gobierno de España
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa
O Secka, DE Berg, M Antonio, T Corrah, M Tapgun, R Walton, V Thomas, ...
Antimicrobial agents and chemotherapy 57 (3), 1231-1237, 2013
Órdenes: US National Institutes of Health
Discovery of novel inhibitors of amyloid β-peptide 1–42 aggregation
LC López, S Dos-Reis, A Espargaró, JA Carrodeguas, ML Maddelein, ...
Journal of Medicinal Chemistry 55 (22), 9521-9530, 2012
Órdenes: Gobierno de España
The FurA regulon in Anabaena sp. PCC 7120: in silico prediction and experimental validation of novel target genes
A Gonzalez, VE Angarica, J Sancho, MF Fillat
Nucleic Acids Research 42 (8), 4833-4846, 2014
Órdenes: Gobierno de España
Benzbromarone, quercetin, and folic acid inhibit amylin aggregation
LC López, O Varea, S Navarro, JA Carrodeguas, N Sanchez de Groot, ...
International journal of molecular sciences 17 (6), 964, 2016
Órdenes: Gobierno de España
Allosteric inhibitors of the NS3 protease from the hepatitis C virus
O Abian, S Vega, J Sancho, A Velazquez-Campoy
PLoS One 8 (7), e69773, 2013
Órdenes: Gobierno de España
PrionScan: an online database of predicted prion domains in complete proteomes
V Espinosa Angarica, A Angulo, A Giner, G Losilla, S Ventura, J Sancho
BMC genomics 15, 1-9, 2014
Órdenes: Gobierno de España
LDL receptor/lipoprotein recognition: endosomal weakening of ApoB and ApoE binding to the convex face of the LR 5 repeat
J Martínez‐Oliván, X Arias‐Moreno, A Velazquez‐Campoy, O Millet, ...
The FEBS journal 281 (6), 1534-1546, 2014
Órdenes: Gobierno de España
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
S Peña-Díaz, J Pujols, M Conde-Giménez, A Čarija, E Dalfo, J García, ...
Frontiers in molecular neuroscience 12, 306, 2019
Órdenes: European Commission, Gobierno de España
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
C Suay-Corredera, MR Pricolo, E Herrero-Galán, D Velázquez-Carreras, ...
Journal of Biological Chemistry 297 (1), 2021
Órdenes: Gobierno de España, Government of Italy
Distant and new mutations in CTX-M-1 β-lactamase affect cefotaxime hydrolysis
FJ Pérez-Llarena, F Kerff, O Abián, S Mallo, MC Fernández, M Galleni, ...
Antimicrobial agents and chemotherapy 55 (9), 4361-4368, 2011
Órdenes: Gobierno de España
La información de publicación y financiación se determina de forma automática mediante un programa informático